Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues

被引:2
|
作者
Vieira de Ribeiro, Ana Julia [1 ]
Sandim, Vanessa [1 ]
Ornellas, Antonio Augusto [2 ,3 ]
Reis, Rodrigo Siqueira [4 ]
Domont, Gilberto [4 ]
Alves, Gilda [1 ]
机构
[1] Inst Nacl Canc, Appl Genet Lab, Div Hematol, BR-20230130 Rio De Janeiro, RJ, Brazil
[2] Inst Nacl Canc, Div Urol, BR-20230130 Rio De Janeiro, RJ, Brazil
[3] Hosp Mario Kroeff, Div Urol, Rio De Janeiro, RJ, Brazil
[4] Univ Fed Rio de Janeiro, Inst Chem, Prote Unit, BR-21941 Rio De Janeiro, RJ, Brazil
来源
INTERNATIONAL BRAZ J UROL | 2013年 / 39卷 / 01期
关键词
Carcinoma; Renal Cell; Proteome; Electrophoresis; Polyacrylamide Gel; Kidney; OXIDATIVE STRESS; MESSENGER-RNA; CANCER-CELLS; IDENTIFICATION; EXPRESSION; PROHIBITIN; BIOMARKER;
D O I
10.1590/S1677-5538.IBJU.2013.01.11
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We attempted to detect, for the first time in a Brazilian cohort, differences in protein expression between clear-cell renal cell carcinoma (ccRCC) and their normal adjacent tissues, aiming to identify biomarkers and/or therapeutic target candidates for this disease. Material and Methods: Twenty-four ccRCC and adjacent normal tissues were collected after surgery and their protein extracts were quantified, pooled and separated by two-dimensional polyacrylamide gel electrophoresis (2DE), followed by statistical analysis of the stained gels. Spots of interest were excised from the gels, digested with trypsin and identified by MALDI-TOF-TOF mass spectrometry. Results: Twenty-six differential spots were detected between the two classes of tissues, among which twenty were identified by mass spectrometry and sixteen were found to be non-redundant. Eleven proteins were either underexpressed or undetected in the ccRCC extracts, such as prohibitin and peroxiredoxin-3, whereas five were found to be overexpressed or exclusively detected in the ccRCC extract, including alpha beta crystalin and heat shock protein 27. Conclusions: Several proteins were detected at differential levels when compared to normal adjacent tissues, and, moreover, many have been previously described by their relationship with RCC. Therefore, this work corroborates previous reports on the search for biomarkers for ccRCC, as well as it points out new candidates that may be validated in future studies.
引用
收藏
页码:83 / 94
页数:12
相关论文
共 50 条
  • [31] Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma
    Bradshaw, Patrick T.
    Olsson, Linnea T.
    Sanchez, Alejandro
    Knezevic, Andrea
    Akin, Oguz
    Scott, Jessica M.
    Hakimi, A. Ari
    Russo, Paul
    Caan, Bette J.
    Mourtzakis, Marina
    Furberg, Helena
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (10) : 1375 - 1382
  • [32] Complimentary transcriptomic-metallomic analysis identifies risk of relapse for clear-cell renal cell carcinoma (ccRCC) patients.
    Gulati, Shuchi
    Vemuri, Bhargav
    Secic, Dina
    Shamsaei, Behrouz
    Plas, David R.
    Cunningham, John T.
    Meller, Jarek
    Landero, Julio Alberto
    Czyzyk-Krzeska, Maria F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [33] Expression of erythropoietin and neuroendocrine markers in clear cell renal cell carcinoma (CCRCC)
    Mjones, P.
    Nordrum, I.
    Qvigstad, G.
    Sordal, O.
    Rian, L. L. Martensson
    Waldum, H. L.
    VIRCHOWS ARCHIV, 2017, 471 : S283 - S283
  • [34] Immunobiochemical profile of clear cell renal cell carcinoma (ccRCC): A preliminary study
    Vargova, Daniela
    Dargaj, Jan
    Franova, Sona
    Dohal, Matus
    Luptak, Jan
    Svihra, Jan
    Bris, Lukas
    Grendar, Marian
    Sutovska, Martina
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2023, 42 (05) : 387 - +
  • [35] Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics
    Zhang, Sihong
    Xu, Xianglai
    Wang, Yelin
    Zhu, Yanjun
    Wang, Jiajun
    Wang, Hang
    Guo, Jianming
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (05): : 597 - 608
  • [36] Novel biomarkers and therapeutic targets in clear cell renal cell carcinoma (ccRCC)
    Meseguer Navarro, Anna
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 17 - 18
  • [37] BILATERAL SYNCHRONOUS MULTIFOCAL RENAL CLEAR-CELL CARCINOMA
    Pothen, L.
    Rouviere, H.
    Sleiman, Bou W.
    Aydin, S.
    Feyaerts, A.
    Nica, M-, I
    Lambert, M.
    ACTA CLINICA BELGICA, 2013, 68 (01) : 75 - 76
  • [38] THYROID METASTASIS OF CLEAR-CELL RENAL-CARCINOMA
    LEHUR, PA
    COTE, RA
    POISSON, J
    BOCTOR, M
    ELHILALI, M
    KANDALAFT, N
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1983, 128 (02) : 154 - 156
  • [39] Targeting HIF2α in Clear-Cell Renal Cell Carcinoma
    Ricketts, Christopher J.
    Crooks, Daniel R.
    Linehan, W. Marston
    CANCER CELL, 2016, 30 (04) : 515 - 517
  • [40] Novel treatment strategies in clear-cell metastatic renal cell carcinoma
    van Spronsen, DJ
    de Weijer, KJM
    Mulders, PFA
    De Mulder, RHM
    ANTI-CANCER DRUGS, 2005, 16 (07) : 709 - 717